Celltrion
068270.KS
#829
Rank
A$37.59 B
Marketcap
$172.69
Share price
0.00%
Change (1 day)
-14.34%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Earnings for Celltrion (068270.KS)

Earnings in 2024 (TTM): A$0.71 Billion

According to Celltrion 's latest financial reports the company's current earnings are A$2.58 Billion. a decrease over its 2023 earnings that were of A$0.80 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Celltrion from 2008 to 2024

Annual earnings

Year Earnings Change
2024 A$0.73 B-8.8%
2023 A$0.80 B6.8%
2022 A$0.75 B-21.85%
2021 A$0.96 B10.25%
2020 A$0.87 B65.16%
2019 A$0.52 B16.64%
2018 A$0.45 B-33.89%
2017 A$0.68 B106.53%
2016 A$0.33 B25.57%
2015 A$0.26 B-6.54%
2014 A$0.28 B47.36%
2013 A$0.19 B-33.63%
2012 A$0.28 B
2010 A$0.14 B72.84%
2009 A$86.63 M260.54%
2008 A$24.02 M